companydata.dkNORDIC BIOSCIENCE HOLDING A/S
CVR: 30511271
The financial health of NORDIC BIOSCIENCE HOLDING A/S appears strong, particularly in 2024, where it reported a revenue of 527.4 million DKK and a profit of 170.8 million DKK, indicating significant growth compared to previous years. The profit margin has improved notably, rising from 17 million DKK in 2023 to 170.8 million DKK in 2024, reflecting a robust operational performance. Equity has also increased substantially, reaching 230.9 million DKK in 2024, suggesting a solid capital position. However, the lack of revenue data for prior years raises concerns about consistency and transparency in financial reporting. Overall, the company is well-positioned within its industry, showcasing strong profitability and a healthy equity base.
AI-generated summary
Overview
- Company type
- A/S
- Aktieselskab
- Founded
- 29.6.2007
Details
- Industry
- Ikke-finansielle holdingselskaber
- Code: 642120
- Secondary industries
- Administrations- og kontorserviceaktiviteter (821000)
- Capital
- 10.616.384,44 kr.
Contact
Advertising protected- Phone
- Log in to see
- Log in to see
- Website
- www.nordicbioscience.com
Purpose
Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed, herunder udvikling, produktion og salg af diagnostiske kit samt eje datterselskaber i forbindelse hermed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 527.4 mio. | 170.8 mio. | 720.3 mio. | 230.9 mio. | 176 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area